These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 32936748)
21. From translational research to open technology innovation systems. Savory C; Fortune J J Health Organ Manag; 2015; 29(2):200-20. PubMed ID: 25800333 [TBL] [Abstract][Full Text] [Related]
22. Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics. Khatab Z; Yousef GM Crit Rev Clin Lab Sci; 2021 Dec; 58(8):546-562. PubMed ID: 34297653 [TBL] [Abstract][Full Text] [Related]
23. Development of health biotechnology in developing countries: can private-sector players be the prime movers? Abuduxike G; Aljunid SM Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902 [TBL] [Abstract][Full Text] [Related]
24. Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs. De Pieri A; Ribeiro S; Tsiapalis D; Eglin D; Bohner M; Dubruel P; Procter P; Zeugolis DI; Bayon Y J Mater Sci Mater Med; 2018 Jul; 29(8):129. PubMed ID: 30066293 [TBL] [Abstract][Full Text] [Related]
25. 'Innovation policy is a team sport' - insights from non-governmental intermediaries in Canadian innovation ecosystem. Tamtik M Triple Helix (Heidelb); 2018; 5(1):8. PubMed ID: 30931242 [TBL] [Abstract][Full Text] [Related]
26. The Quadruple Helix-Based Innovation Model of Reference Sites for Active and Healthy Ageing in Europe: The Ageing@Coimbra Case Study. Malva JO; Amado A; Rodrigues A; Mota-Pinto A; Cardoso AF; Teixeira AM; Todo-Bom A; Devesa A; Ambrósio AF; Cunha AL; Gomes B; Dantas C; Abreu C; Santana I; Bousquet J; Apóstolo J; Santos L; Meneses de Almeida L; Illario M; Veríssimo R; Rodrigues V; Veríssimo MT Front Med (Lausanne); 2018; 5():132. PubMed ID: 29868588 [TBL] [Abstract][Full Text] [Related]
27. [Consideration on Industry-Academia Partnering in Drug Discovery Development: Based on a Questionnaire Survey of Pharmaceutical Companies and Academia]. Iida K; Yano T; Ikemori M; Ishida T; Nishimura N Yakugaku Zasshi; 2021 Jun; 141(6):877-886. PubMed ID: 33642438 [TBL] [Abstract][Full Text] [Related]
28. Leadership of healthcare commissioning networks in England: a mixed-methods study on clinical commissioning groups. Zachariadis M; Oborn E; Barrett M; Zollinger-Read P BMJ Open; 2013; 3(2):. PubMed ID: 23430596 [TBL] [Abstract][Full Text] [Related]
29. Advancing evidence-based digital health through an innovative research environment: an academic-industry collaboration case report. Ford KL; Moore SL; Zhou S; Gore MO; Portz J; Zhang X; Zane R; Wiler J; Bull S Mhealth; 2019; 5():37. PubMed ID: 31620464 [TBL] [Abstract][Full Text] [Related]
30. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
31. Strengthening the Bridge Between Academic and the Industry Through the Academia-Industry Collaboration Plan Design Model. Ahmed F; Fattani MT; Ali SR; Enam RN Front Psychol; 2022; 13():875940. PubMed ID: 35734456 [TBL] [Abstract][Full Text] [Related]
32. [Aiming for zero blindness]. Nakazawa T Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109 [TBL] [Abstract][Full Text] [Related]
33. Improving the quality of workers' compensation health care delivery: the Washington State Occupational Health Services Project. Wickizer TM; Franklin G; Plaeger-Brockway R; Mootz RD Milbank Q; 2001; 79(1):5-33. PubMed ID: 11286095 [TBL] [Abstract][Full Text] [Related]
34. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated. Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672 [TBL] [Abstract][Full Text] [Related]
35. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007). Hafner J J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862 [TBL] [Abstract][Full Text] [Related]
36. Drug Target Identification and Validation: Global Pharmaceutical Industry Experts on Challenges, Best Strategies, Innovative Precompetitive Collaboration Concepts, and Future Areas of Industry Precompetitive Research and Development. Bergauer T; Ruppert T; Essioux L; Spleiss O Ther Innov Regul Sci; 2016 Nov; 50(6):769-776. PubMed ID: 30231745 [TBL] [Abstract][Full Text] [Related]
37. Defining Success in Open Science. Ali-Khan SE; Jean A; MacDonald E; Gold ER MNI Open Res; 2018; 2():2. PubMed ID: 29553146 [TBL] [Abstract][Full Text] [Related]
38. Public-private partnership models in France and in Europe. Demotes-Mainard J; Canet E; Segard L Therapie; 2006; 61(4):325-34, 313-23. PubMed ID: 17124948 [TBL] [Abstract][Full Text] [Related]
39. The Innovative Medicines Initiative -10 Years of Public-Private Collaboration. Laverty H; Meulien P Front Med (Lausanne); 2019; 6():275. PubMed ID: 31850354 [TBL] [Abstract][Full Text] [Related]